Hycor Biomedical Still Buying
IRVINE — Hycor Biomedical Inc. said it plans to repurchase another 800,000 shares of its common stock on the open market from time to time.
To date, Hycor Biomedical has repurchased more than 1.6 million shares, the company said. It completed a repurchase program of 820,000 shares last week. Hycor Biomedical, which develops and produces medical diagnostic products, said it has about 7.5 million shares outstanding.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
